AVHHL - AVITA Therapeutics Inc. (RCEL) CEO Mike Perry on Q2 2021 Results - Earnings Call Transcript

AVITA Therapeutics, Inc. (RCEL) Q2 2021 Earnings Conference Call February 11, 2021 4:30 PM ET Company Participants Caroline Corner - Investor Relations, Westwicke Mike Perry - Chief Executive Officer Sean Ekins - Interim Principal Financial Officer and Accounting Officer Erin Liberto - Chief Commercial Officer Andrew Quick - Chief Technology Officer Conference Call Participants Josh Jennings - Cowen Kevin DeGeeter - Oppenheimer & Co Ryan Zimmerman - BTIG Brooks O'Neil - Lake Street Capital Markets Lyanne Harrison - Bank of America John Hester - Bell Potter Presentation Operator Ladies and gentlemen, thank you for standing by. And welcome to the AVITA Medical Second Quarter Earnings Conference Call. [Operator Instructions] Please be advised that today's conference maybe record. I'd now like to hand the conference over to your speaker today, Ms. Caroline Corner with Westwicke. Please go ahead ma'am. Caroline Corner Thank you, operator. Welcome to AVITA Medical's first fiscal second

For further details see:

AVITA Therapeutics, Inc. (RCEL) CEO Mike Perry on Q2 2021 Results - Earnings Call Transcript